title: Novel Variant of Miller Fisher Syndrome Occurring With Tumor Necrosis Factor α Antagonist Therapy.
authors.affiliation: John Radcliffe Hospital, Oxford, England.
authors.forename: Gokulan
authors.initials: G
authors.lastname: Ratnarajan
authors.affiliation: John Radcliffe Hospital, Oxford, England.
authors.forename: Alexander
authors.initials: A
authors.lastname: Thompson
authors.affiliation: John Radcliffe Hospital, Oxford, England.
authors.forename: Caroline
authors.initials: C
authors.lastname: Dodridge
authors.affiliation: John Radcliffe Hospital, Oxford, England.
authors.forename: Allyson
authors.initials: A
authors.lastname: Parry
authors.affiliation: John Radcliffe Hospital, Oxford, England.
authors.forename: John
authors.initials: J
authors.lastname: Elston
mesh_terms: D000328:Adult; D003093:Colitis, Ulcerative / Q000188:drug therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab / Q000009:adverse effects*; D019846:Miller Fisher Syndrome / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab